Notably, our current studies also indicate that intra-tumoral CD4+ and CD8+ T cells, as well as the ratio of CD4/CD8 in TILs are all valuable and significant prognostic biomarkers for predicting the outcomes of human breast cancer. The gene discussed is CD4; the disease is breast cancer.